---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-106454"
form_type: "8-K"
ticker: "NMTC"
cik: "0001500198"
company_name: "NEUROONE MEDICAL TECHNOLOGIES Corp"
filed_at: "2025-11-05T23:59:59+00:00"
generated_at: "2026-05-17T00:15:26.953693+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NeuroOne Medical receives Nasdaq extension to May 4, 2026 to regain $1.00 bid price compliance

## Summary
- Nasdaq granted a 180-day extension until May 4, 2026 for minimum bid price compliance.
- Company previously disclosed non-compliance on May 9, 2025; initial cure period expired Nov 3, 2025.
- If not compliant by May 4, 2026, Nasdaq may delist; company can appeal to a hearing panel.
- Listing remains fully effective during extension; no immediate impact on common stock trading.

## SEC filing metadata
- accession: 0001213900-25-106454
- form_type: 8-K
- ticker: NMTC
- cik: 0001500198
- company_name: NEUROONE MEDICAL TECHNOLOGIES Corp
- filed_at: 2025-11-05T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1500198/000121390025106454/0001213900-25-106454-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1500198/000121390025106454/ea0263939-8k_neuroone.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-106454
- JSON: https://secwatch.observer/filing/0001213900-25-106454.json
- Plain text: https://secwatch.observer/filing/0001213900-25-106454.txt

## Source-grounded claims
- claim_id: b2d3ce3941a1456e4731bd255ea66211a5eba8a2
  claim: NEUROONE MEDICAL TECHNOLOGIES Corp received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).
  evidence_excerpt: November 4, 2025, NeuroOne Medical Technologies Corporation (the “Company”) received a letter (the “Extension Notice”) from the Listing Qualifications Staff of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that Nasdaq has granted the Company a 180-day extension, until May 4, 2026 (the “Extension Period”), to regain compliance with the requirement for the Company’s common stock, par value $0.001 per share (“Common Stock”), to maintain a minimum bid price of $1.00 per share for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Mi
  evidence_url: https://www.sec.gov/Archives/edgar/data/1500198/000121390025106454/0001213900-25-106454-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.